AstraZeneca adds Latin America to Ionis ATTR partnership for $20M

AstraZeneca adds Latin America to Ionis ATTR partnership for $20M

Source: 
Fierce Biotech
snippet: 

AstraZeneca has secured the last piece to a global puzzle of licensing agreements with Ionis Pharmaceuticals for the rare heart disease drug eplontersen.